ARTICLE | Management Tracks
Henderson new board chair at Cytokinetics
Plus Spear resigns at Poseida and updates from Cambridge Enterprise and Gaba
April 8, 2022 11:52 PM UTC
John Henderson is the new board chair at Cytokinetics Inc. (NASDAQ:CYTK), following the retirement of Patrick Gage. Henderson has served on the board since 2009, and was employed by Pfizer Inc. (NYSE:PFE) for more than 25 years, including as VP in the pharmaceuticals group.
Cell and gene therapy company Poseida Therapeutics Inc. (NASDAQ:PSTX) disclosed in an SEC filing that Matthew Spear will resign as CMO on April 22, to pursue another opportunity. The company has yet to announce a successor...